Scott Wilkins
Family Medicine · Orrville, OHNPI 1912360348
Payments from drug & device makers
Across 168 payments — averaging $17.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$478
- AbbVie$409
- AstraZeneca$264
- Xeris Pharmaceuticals, Inc.$201
- Astellas Pharma US Inc$183
- Novo Nordisk$182
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,91698%
- Education$662%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 32 | $478 |
| AbbVie | 23 | $409 |
| AstraZeneca | 9 | $264 |
| Xeris Pharmaceuticals, Inc. | 11 | $201 |
| Astellas Pharma US Inc | 8 | $183 |
| Novo Nordisk | 8 | $182 |
| Bayer | 12 | $168 |
| Amgen | 10 | $157 |
| Exact Sciences | 7 | $123 |
| Boehringer Ingelheim | 7 | $107 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $82 |
| Sanofi-aventis U.S. LLC | 4 | $72 |
| Dynavax Technologies Corporation | 3 | $59 |
| Sanofi Pasteur Inc. | 3 | $50 |
| Merck | 3 | $50 |
| Novartis | 3 | $47 |
| Inspire Medical Systems, Inc. | 2 | $45 |
| Pfizer | 2 | $41 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 2 | $32 |
| Dexcom, Inc. | 2 | $30 |
| GSK | 2 | $29 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Shield Therapeutics Inc | 1 | $18 |
| Optinose US, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| VBI Vaccine (delaware) Inc. | 1 | $17 |
| Seqirus USA Inc | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,982 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 192 | $204,137 |
| EliquisApixaban | 157 | $182,226 |
| FarxigaDapagliflozin Propanediol | 111 | $117,236 |
| OzempicSemaglutide | 90 | $94,244 |
| MounjaroTirzepatide | 74 | $81,473 |
| JardianceEmpagliflozin | 76 | $72,108 |
| XareltoRivaroxaban | 46 | $40,034 |
| Repatha SureclickEvolocumab | 44 | $39,060 |
| EntrestoSacubitril/Valsartan | 25 | $32,362 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 37 | $28,874 |
| RybelsusSemaglutide | 17 | $26,830 |
| VraylarCariprazine Hcl | 16 | $24,789 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 21 | $21,927 |
| MyrbetriqMirabegron | 35 | $18,454 |
| Breo ElliptaFluticasone/Vilanterol | 33 | $17,605 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $478 | $285,609266 claims |
| PfizerEliquis | $41 | $182,226157 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $264 | $143,644149 claims |
| Novo NordiskOzempic, Rybelsus | $182 | $121,074107 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $107 | $79,35587 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $29 | $46,47970 claims |
| AbbVieVraylar, Linzess | $409 | $35,08227 claims |
| NovartisEntresto | $47 | $32,36225 claims |
| Astellas Pharma US IncMyrbetriq | $183 | $18,45435 claims |
| MerckJanuvia | $50 | $7,42513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Orrville
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.